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ISSCR: Annual ReportLetter from the Executive DirectorAs executive director, I am often congratulated on the phenom-
enal success of the ISSCR. People in the field are amazed by the
stature the society has achieved in the span of only 6 years. Sev-
eral members of the Global Advisory Council have observed that
the ISSCR’s greatest asset was its strategic decision to involve
from the outset the field’s top thought-leaders as officers, direc-
tors, and committee chairs.
These decisions were made well before I came along and are
due to the vision of the ISSCR’s founder, Leonard Zon, who rec-
ognized that, in order for the society to become world class, it
needed to be embraced by world-class scientists.
Dr. Zon’s selection of The Sherwood Group, Inc. to administer
the society was also based on a key strategic insight, inasmuch
as he had worked with Greg Schultz, the ISSCR’s first executive
director, when president of another society. Simply stated, asso-
ciation management companies such as The Sherwood Group
provide smaller nonprofit organizations with access to highly
skilled and experienced association professionals who would
not otherwise be available to them. Each job is performed by
the right person working at the right level, maximizing return on
an organization’s staff and headquarters investment.
Three headquarters staff members work full time with the
ISSCR, includingme;Michael Hagedorn, administrative director;
and Ryan Detwiler, manager of committees and outreach.
Heather Rooke, the ISSCR’s science editor, is based in Boston
and has a full-time independently fundedposition through a grant
from the Juvenile Diabetes Research Foundation (JDRF).
I believe another key to the society’s success is the integration
of effort between the Board of Directors, committees, and staff.
In step with our overall membership growth, our committees
have grown in number and in the scope of their activities and pro-
gressed from bare-bones efforts in the first few years, with no di-
rect staffing and virtually no year-round communications, to an
increasingly important governing system for the society. In addi-
tion to face-to-face meetings during the annual meeting, com-
mittees meet by conference call on an as-needed basis. Com-
mittee chairs and assigned staff work closely to ensure that
this system functions smoothly—not an easy task given the geo-
graphic dispersion of themembers and themany time zones that
need to be considered.
All committee activities are vetted by the Board of Directors,
whichmeets in person twice a year, or by the Executive Commit-
tee, which meets monthly by conference call in order to address
issues that need immediate attention. The newly formed Global
Advisory Council will convene annually with leaders of the ISSCRin a Global Forum. All in all, this represents an extremely active
year-round administrative effort.
As executive director, my primary responsibility is to support
and coordinate the vision, leadership, and strategy efforts of
our Board of Directors. A privilege of this position is having a clear
view of the goals of each year’s president, and this past year
working with George Q. Daley has been particularly rewarding.
The continuity of my position allows me to maintain the strategic
themes from president to president, and to implement communi-
cations and administrative structures that enable us to foster
new alliances.
I am mindful that the society does not operate in a vacuum,
and one of the most gratifying aspects of my position is the op-
portunity to represent the ISSCR atmeetings sponsored by other
organizations. We are at a stage of development where alliances
with other key policy-setting organizations are a necessity, and
ISSCR leaders are currently evaluating the potential for closer re-
lationships with groups such as the International Stem Cell Fo-
rum (ISCF).
The annual meeting remains the cornerstone event for the so-
ciety. Predicting the growth of the society—and of the annual
meeting—is an ongoing challenge for both the staff and the lead-
ership. What, specifically, will be the impact of increased recruit-
ment among translational, clinical, and industrial scientists?
What directionswill stemcell research take in the next few years?
These issues, and more, have a direct bearing on how the staff
plans to accommodate the needs of the society in the future.
I look forward to working closely with the ISSCR’s new presi-
dent, Fiona Watt, and the entire ISSCR leadership and staff to
find balanced answers to these questions, and to address our in-
creasingly sophisticated requirements with creative responses.
Nancy R. Witty
Executive Director
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